Anil Tombak

Mersin, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Practical Guidance on the Clinical Management of Belantamab Mafodotin for Patients With Relapsed/Refractory Multiple Myeloma: Recommendations From the Middle East and North Africa Expert Panel.

Practical Guidance on the Clinical Management of Belantamab Mafodotin for Patients With Relapsed/Refractory Multiple Myeloma: Recommendations From the Middle East and North Africa Expert Panel.

Journal: Clinical lymphoma, myeloma & leukemia

Published: April 23, 2025

Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis

Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: November 06, 2024

Extranodal Nasal-Type NK/T-Cell Lymphoma Treatment: Analysis from a Multicenter Study.

Extranodal Nasal-Type NK/T-Cell Lymphoma Treatment: Analysis from a Multicenter Study.

Journal: Nigerian journal of clinical practice

Published: August 03, 2024

Roxadustat versus placebo for patients with lower-risk myelodysplastic syndrome: MATTERHORN phase 3, double-blind, randomized controlled trial.

Roxadustat versus placebo for patients with lower-risk myelodysplastic syndrome: MATTERHORN phase 3, double-blind, randomized controlled trial.

Journal: American journal of hematology

Published: May 06, 2024

The etiology of chronic splanchnic vein thrombosis in adults: a two-center analysis.

The etiology of chronic splanchnic vein thrombosis in adults: a two-center analysis.

Journal: American journal of blood research

Published: April 12, 2024

Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria.

Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria.

Journal: American journal of hematology

Published: March 20, 2024

Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data.

Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data.

Journal: Hematological oncology

Published: October 25, 2022

Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study.

Ruxolitinib Reduces Oxidative Stress in Patients With Primary Myelofibrosis: A Multicenter Study.

Journal: Cureus

Published: January 04, 2022

Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study.

Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study.

Journal: European journal of internal medicine

Published: December 19, 2021

Thiol/Disulfide Balance in Older Patients with BCR-ABL Negative Myeloproliferative Neoplasms.

Thiol/Disulfide Balance in Older Patients with BCR-ABL Negative Myeloproliferative Neoplasms.

Journal: Clinical laboratory

Published: December 15, 2021

Real world results of venetoclax combined with hypomethylating agents in relapsed/refractory AML.

Real world results of venetoclax combined with hypomethylating agents in relapsed/refractory AML.

Journal: European review for medical and pharmacological sciences

Published: November 17, 2021

Integration of low muscle mass into the IPS system and its prognostic significance in patients with Hodgkin's lymphoma.

Integration of low muscle mass into the IPS system and its prognostic significance in patients with Hodgkin's lymphoma.

Journal: Biomarkers in medicine

Published: November 10, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026